Astrana Health (ASTH)

• Market cap: $1.35B
• 1 day: -3.97%
• 5 days: -3.66%
• 1 month: 12.46%
• 3 months: -7.52%
• 6 months: -48.51%
• Year to date: -7.52%
• 1 year: -29.16%
• 5 years: 141.92%
• 10 years: 197.80%
• Sector: Industrials
• Industry: Management Consulting Services

About: Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Employees: 1,900

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,466% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $921K

24% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 54

1.18% more ownership

Funds ownership: 45.13% [Q3] → 46.31% (+1.18%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

6% less funds holding

Funds holding: 189 [Q3] → 178 (-11) [Q4]

24% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 41

44% less capital invested

Capital invested by funds: $1.47B [Q3] → $822M (-$648M) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $36 21% upside
• Avg. target: $47 59% upside
• High target: $56 88% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Barclays Andrew Mok 41% 1-year accuracy 24 / 58 met price target	21% upside $36	Equal-Weight Initiated	1 Apr 2025
Truist Securities Jailendra Singh 37% 1-year accuracy 13 / 35 met price target	54% upside $46	Buy Maintained	18 Mar 2025
B of A Securities Adam Ron 75% 1-year accuracy 3 / 4 met price target	65% upside $49	Buy Maintained	4 Mar 2025
Baird Michael Ha 47% 1-year accuracy 9 / 19 met price target	68% upside $50	Outperform Maintained	3 Mar 2025
Stifel Craig Jones 56% 1-year accuracy 5 / 9 met price target	88% upside $56	Buy Maintained	20 Feb 2025